The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art

被引:361
作者
Arnaoutova, Irina [2 ]
George, Jay [2 ]
Kleinman, Hynda K. [1 ,2 ]
Benton, Gabriel [2 ]
机构
[1] NIDCR, NIH, Bethesda, MD 20892 USA
[2] Trevigen Inc, Gaithersburg, MD USA
关键词
Angiogenesis; Basement membrane; Endothelial cell tubes; Morphological differentiation; Quantitative assay; High throughput screen; CAPILLARY-LIKE STRUCTURES; IN-VITRO; EXTRACELLULAR-MATRIX; BIOLOGICAL-ACTIVITY; GENE-EXPRESSION; GROWTH-FACTORS; ANGIOGENESIS; LAMININ; TUMOR; DIFFERENTIATION;
D O I
10.1007/s10456-009-9146-4
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
It has been more than 20 years since it was first demonstrated that endothelial cells will rapidly form capillary-like structures in vitro when plated on top of a reconstituted basement membrane extracellular matrix (BME, Matrigel, EHS matrix, etc.). Subsequently, this morphological differentiation has been demonstrated with a variety of endothelial cells; with endothelial progenitor cells; and with transformed/immortalized endothelial cells. The differentiation process involves several steps in blood vessel formation, including cell adhesion, migration, alignment, protease secretion, and tubule formation. Because the formation of vessel structures is rapid and quantifiable, endothelial cell differentiation on basement membrane has found numerous applications in assays. Such differentiation has been used (1) to study angiogenic and antiangiogenic factors, (2) to define mechanisms and pathways involved in angiogenesis, and (3) to define endothelial cell populations. Further, the endothelial cell differentiation assay has been successfully used to study processes ranging from wound repair and reproduction to development and tumor growth. The assay is easy to perform and is the most widely used in vitro angiogenesis assay.
引用
收藏
页码:267 / 274
页数:8
相关论文
共 38 条
[1]   HMEC-1 - ESTABLISHMENT OF AN IMMORTALIZED HUMAN MICROVASCULAR ENDOTHELIAL-CELL LINE [J].
ADES, EW ;
CANDAL, FJ ;
SWERLICK, RA ;
GEORGE, VG ;
SUMMERS, S ;
BOSSE, DC ;
LAWLEY, TJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (06) :683-690
[2]   The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation [J].
Albini, Adriana ;
Benelli, Roberto .
NATURE PROTOCOLS, 2007, 2 (03) :504-511
[3]   Angiogenesis assays: A critical overview [J].
Auerbach, R ;
Lewis, R ;
Shinners, B ;
Kubai, L ;
Akhtar, N .
CLINICAL CHEMISTRY, 2003, 49 (01) :32-40
[4]  
Bagley RG, 2003, CANCER RES, V63, P5866
[5]   In vitro models of angiogenesis:: the use of Matrigel [J].
Benelli, R ;
Albini, A .
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1999, 14 (04) :243-246
[6]   The evolving role of thrombospondin-1 in hemostasis and vascular biology [J].
Bonnefoy, A. ;
Moura, R. ;
Hoylaerts, M. F. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2008, 65 (05) :713-727
[7]   The effects of growth factors on the proliferation and in vitro angiogenesis of human macular inner choroidal endothelial cells [J].
Browning, A. C. ;
Dua, H. S. ;
Amoaku, W. M. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (07) :1003-1008
[8]   IDENTIFICATION OF HAPTOGLOBIN AS AN ANGIOGENIC FACTOR IN SERA FROM PATIENTS WITH SYSTEMIC VASCULITIS [J].
CID, MC ;
GRANT, DS ;
HOFFMAN, GS ;
AUERBACH, R ;
FAUCI, AS ;
KLEINMAN, HK .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :977-985
[9]   Fibulins: Multiple roles in matrix structures and tissue functions [J].
de Vega, S. ;
Iwamoto, T. ;
Yamada, Y. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2009, 66 (11-12) :1890-1902
[10]   Halofuginone: a potent inhibitor of critical steps in angiogenesis progression [J].
Elkin, M ;
Miao, HQ ;
Nagler, A ;
Aingorn, E ;
Reich, R ;
Hemo, I ;
Dou, HL ;
Pines, M ;
Vlodavsky, I .
FASEB JOURNAL, 2000, 14 (15) :2477-2485